Trends in prognostic factors and survival from cutaneous melanoma in Yorkshire, UK and New South Wales, Australia between 1993 and 2003

International Journal of Cancer

Volumn 123, Issue 4, 2008, Pages 861-866

  Downing, Amy ^a,b   Xue, Qin Yu ^b   Newton Bishop, Julia ^c   Forman, David ^a,b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c CANCER RESEARCH DIVISION   (Australia)

Author keywords

Incidence; Melanoma; Survival

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUSTRALIA; BRESLOW THICKNESS; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER INVASION; CANCER LOCALIZATION; CANCER PREVENTION; CANCER REGISTRY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONFIDENCE INTERVAL; CUTANEOUS MELANOMA; DATA BASE; DEATH; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; SEX DIFFERENCE; SOCIAL STATUS; TUMOR VOLUME; UNITED KINGDOM; AGE; CARCINOMA IN SITU; INCIDENCE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SKIN TUMOR; SOCIOECONOMICS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA IN SITU; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; NEW SOUTH WALES; PROGNOSIS; SEX FACTORS; SKIN NEOPLASMS; SOCIOECONOMIC FACTORS;

EID: 47049123542     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23495     Document Type: Article

References (27)

1. Cancer Research UK. UK Malignant Melanoma incidence statistics. 2005. [Internet] 2005 [Cited 2007 November]. Available from http://info. cancerresearchuk.org/cancerstats/types/melanoma/incidence/.
2. de Vries E, Coebergh JWW. Melanoma incidence has risen in Europe. Br Med J 2005;331:698.
3. Downing A, Newton-Bishop JA, Forman D. Recent trends in cutaneous malignant melanoma in the Yorkshire region of England; incidence, mortality and survival in relation to stage of disease, 1993-2003. Brit J Cancer 2006;95:91-5.
4. Marrett LD, Nguyen HL, Armstrong BK. Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983-1996. Int J Cancer 2001;92:457-62.
5. Coory M, Baade P, Aitken J, Smithers M, McLeod GRC, Ring I. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002. Cancer Causes Control 2006;17:21-7.
6. Jemal A, Devesa SS, Hartge P, Tucker MA. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst 2001;93:678-83.
7. Burton RC, Armstrong BK. Recent trends imply a non mctastasising form of invasive melanoma. Melanoma Res 1994;4:107-13.
8. Holme SA, Malinovsky K, Roberts DL. Malignant melanoma in South Wales: changing trends in presentation (1986-98). Clin Exp Dermatol 2001;26:484-9.
9. MacKie R, Bray C, Hole DJ, Morris A, Nicolson M, Evans A, Doherty V, Vestey J. Incidence of and survival from malignant melanoma in Scotland: an epidemiological study. Lancet 2002;360:587-91.
10. Cummins DL, Cummins JM, Pantle H, Silverman MA, Leonard AL, Chanmugam A. Cutaneous malignant melanoma. Mayo Clin Proc 2006;81:500-7.
11. World Health Organisation. International statistical classification of diseases and related health problems 10th revision. Geneva: WHO, 1992.
12. American Joint Committee on Cancer. Manual for staging of cancer. Philadelphia: Lippincott, 2002. 209-20.
13. Townsend P, Phillimore P. Health and deprivation. Inequality and the north. London: Routledge, 1988.
14. Australian Bureau of Statistics. Information paper: 1996 Census Socio-Economic Indexes For Areas (SEIFA). Canberra: ABS, 1998.
15. Segi M. Cancer mortality for selected sites in 24 countries (1950-57). Sendai, Japan: Department of Public Health, Tohoku University of Medicine, 1960.
16. Ederer F, Axtell LM, Cutler SJ. The relative survival rate: a statistical methodology. Nat Cancer Inst Monogr 1961;6:101-20.
17. Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med 2004;23:51-64.
18. Yu XQ, O'Connell DL, Gibberd RW, Smith DP, Dickman PW, Armstrong BK. Estimating regional variation in cancer survival: a tool for improving cancer care. Cancer Causes Control 2004;15:611-18.
19. Yu XQ, O'Connell DL, Gibberd RW, Armstrong BK. A population-based study from New South Wales, Australia 1996-2001: area variation in survival from colorectal cancer. Eur J Cancer 2005;41:2715-21.
20. Hill D, White V, Marks R, Borland R. Changes in sun-related attitudes and behaviours, and reduced sunburn prevalence in a population at high risk of melanoma. Eur J Cancer Prev 1993;2:447-556.
21. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Picconi O, Boyle P, Melchi CF. Meta-analysis of risk factors for cutaneous melanoma. II. Sun exposure. Eur J Cancer 2005;4145-60.
22. Luke CG, Coventry BJ, Foster-Smith EJ, Roder DM. A critical analysis of reasons for improved survival from invasive cutaneous melanoma. Cancer Causes Control 2003;14:871-8.
23. Elder D, Murphy G. Malignant tumors (melanomas and related lesions). Atlas of tumor pathology: melanocytic tumors of the skin 2 (Third series). Washington, DC: AFIP (Armed Forces Institute of Pathology); 1991:103-205.
24. Bonett A, Roder A, Esterman A. Epidemiological features of melanoma in South Australia: implications for cancer control. Med J Aust 1989;151:502-9.
25. Thorn M, Ponten F, Johansson A, Bergstrom R. Rapid increase in diagnosis of cutaneous melanoma in situ in Sweden. Cancer Detect Prev 1998;22:430-7.
26. Lee JA. The systematic relationship between melanomas diagnosed in situ and when invasive. Melanoma Res 2001;11:523-9.
27. Welch HG, Woloshin S, Schwartz LM. Skin biopsy rates and incidence of melanoma: population based ecological study. Br Med J 2005;331:481.